Back

Cost-effectiveness of secondary prevention

11 April 2019 (14:45 - 15:07)
Organised by:
Congress Presentation Part of: Cardiovascular prevention: is it worth the money? Public Health and Health Economics EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Ms Gemma E Shields

Manchester (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
The economic burden of cardiovascular disease.
Professor F. Pinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Cost-effectiveness of primary prevention.
Professor O. Franco Duran (Bern, CH)
Slides Video
Presentation thumbnail
Cost-effectiveness of telerehabilitation
Doctor I. Frederix (Heerlen, NL)
Slides Video

Access the full session

Session thumbnail
Cardiovascular prevention: is it worth the money?

The Event

Event poster

EuroPrevent 2019

11 April 2019 14:45 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention of coronary artery disease: a retrospective observational analysis of italian healthcare administrative data
7 April 2022
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Cost-effectiveness of Sotagliflozin for the treatment of recent worsening heart failure with diabetes
20 May 2023
thumbnail
Congress Presentation
Cost-effectiveness analysis of implementing the Nagasaki Acute Myocardial Infarction (AMI) secondary prevention clinical pathway
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources